RCMI Coordinating Center (RCMI CC) Header Logo

Sheilah Clayton

Concepts (48)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Nurse's Role
1
2011
35
0.360
 Why?
Breast Neoplasms
5
2017
1679
0.330
 Why?
Clinical Trials as Topic
1
2011
249
0.320
 Why?
Health Services Accessibility
1
2011
680
0.250
 Why?
Minority Groups
1
2011
663
0.250
 Why?
Transforming Growth Factor beta
1
2017
214
0.120
 Why?
Survivors
1
2014
152
0.100
 Why?
Nurse-Patient Relations
1
2011
6
0.090
 Why?
Academic Medical Centers
1
2011
73
0.090
 Why?
Patient Participation
1
2011
87
0.080
 Why?
Patient Selection
1
2011
192
0.080
 Why?
California
1
2011
531
0.080
 Why?
Amino Acid Transport Systems
1
2006
5
0.070
 Why?
Receptor, erbB-2
1
2008
149
0.060
 Why?
Paclitaxel
1
2006
64
0.060
 Why?
Amino Acids
1
2006
150
0.060
 Why?
Proto-Oncogene Proteins c-akt
1
2008
297
0.060
 Why?
Antineoplastic Agents, Phytogenic
1
2006
134
0.060
 Why?
Female
5
2017
24018
0.050
 Why?
Apoptosis
1
2006
1541
0.040
 Why?
Humans
5
2017
42163
0.030
 Why?
Thiosemicarbazones
1
2017
10
0.030
 Why?
Receptors, Transforming Growth Factor beta
1
2017
25
0.030
 Why?
Pyrazoles
1
2017
93
0.030
 Why?
beta Catenin
1
2017
75
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
180
0.030
 Why?
Cell Line, Tumor
2
2017
2598
0.030
 Why?
Evidence-Based Medicine
1
2014
107
0.030
 Why?
Drug Resistance, Neoplasm
1
2017
290
0.030
 Why?
Data Collection
1
2014
210
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2017
933
0.020
 Why?
Disease-Free Survival
1
2008
116
0.020
 Why?
Ethylmaleimide
1
2006
8
0.020
 Why?
Starvation
1
2006
12
0.020
 Why?
Maleimides
1
2006
12
0.020
 Why?
Alanine
1
2006
33
0.020
 Why?
Survival Analysis
1
2008
362
0.020
 Why?
In Situ Nick-End Labeling
1
2006
138
0.020
 Why?
Antibiotics, Antineoplastic
1
2006
52
0.020
 Why?
Sodium
1
2006
101
0.020
 Why?
Caspases
1
2006
148
0.020
 Why?
Doxorubicin
1
2006
95
0.020
 Why?
Immunohistochemistry
1
2008
928
0.010
 Why?
Enzyme Inhibitors
1
2006
457
0.010
 Why?
Dose-Response Relationship, Drug
1
2006
1112
0.010
 Why?
Gene Expression Regulation
1
2006
1066
0.010
 Why?
Cell Proliferation
1
2006
1420
0.010
 Why?
Middle Aged
1
2008
11819
0.010
 Why?
Clayton's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (48)
Explore
_
Co-Authors (4)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support